Dublin, April 26, 2022 (GLOBE NEWSWIRE) -- The "Intraosseous Infusion Devices Market, by Product Type, by Technology, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 ...
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb 3, 2016) - Pyng Medical Corp. (TSX VENTURE:PYT), an award-winning developer of trauma and resuscitation products for emergency, combat and critical care ...
NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that its ...
PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System
The PortIO Intraosseous Infusion System consists of an implantable intraosseous vascular access device and insertion kit. Instead of a catheter located in a vein, it has a short extension from the ...
Future Market Insights delivers key insights on the global Intraosseous Infusion Devices market in a new publication titled “Intraosseous Infusion Devices Market: Global Industry Analysis & ...
September 7, 2010 — The US Food and Drug Administration (FDA) has granted 510(k) clearance for a next-generation sternal intraosseous infusion system (FASTx; Pyng Medical Corp). The device is ...
According to a recent study by Future Market Insights (FMI), the global intraosseous (IO) infusion devices is expected to witness high growth during the forecast period. The market is expected to grow ...
Pavmed Inc. implanted its Portio system in three patients in a first-in-human (FIH) study of its intraosseous infusion system and successfully infused fluids in all patients without complications. The ...
Intraosseous cannulation is an accepted means to achieve vascular access when peripheral venous access is not available. It is common practice to flush the intraosseous cannula with saline prior to ...
Please provide your email address to receive an email when new articles are posted on . According to published results, an intraosseous infusion of antibiotics combined with morphine offered ...
PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System
First three patients underwent successful implantation and clinical utilization of PortIO as part of a first-in-human study in Colombia, South America NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results